News
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025; UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of Euro ...
Investigators systematically evaluate the efficacy differences of existing treatment regimens for IgA nephropathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback